{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifwc6tb7imodr4s7zz7ax5iqs6zvp6g23adplcnk6hl2dqer2y4z4",
    "uri": "at://did:plc:q27hltg3oatmy4g7oio4vbc3/app.bsky.feed.post/3mjrnthsd5yz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaxaxppjzxn5leqalld4xo7fnnbnsejddwslzfsq37rwbues2euha"
    },
    "mimeType": "image/jpeg",
    "size": 168026
  },
  "path": "/health/medicine-drugs/experimental-drug-doubles-one-year-survival-in-pancreatic-cancer",
  "publishedAt": "2026-04-18T13:00:00.000Z",
  "site": "https://www.livescience.com",
  "tags": [
    "Medicine & Drugs",
    "Health"
  ],
  "textContent": "A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.",
  "title": "Experimental drug doubles one-year survival in pancreatic cancer"
}